about
Efficacy of vaginal danazol treatment in women with menorrhagia during fertile ageThe addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia.The search for thrombophilic gene mutations in women with gestational hypertension does not help in predicting poor pregnancy outcome.Placental stress factors and maternal-fetal adaptive response: the corticotropin-releasing factor family.Activin-A and myostatin response and steroid regulation in human myometrium: disruption of their signalling in uterine fibroidThe influence of doctor-patient and midwife-patient relationship in quality care perception of italian pregnant women: an exploratory study.Inhibins and activins in pregnancy.Tissue-Specific Cultured Human Pericytes: Perivascular Cells from Smooth Muscle Tissue Have Restricted Mesodermal Differentiation AbilityThe identification of high risk pregnancy: a new challenge in obstetrics.Neuroendocrine aspects of placenta and pregnancy.Understanding spontaneous preterm birth: from underlying mechanisms to predictive and preventive interventions.Endocrinology of human parturition.Urocortin 2 role in placental and myometrial inflammatory mechanisms at parturition.Preimplantation and prenatal diagnosis, wrongful birth and wrongful life: a global view of bioethical and legal controversies.Twin pregnancies after assisted reproductive technologies: the role of maternal age on pregnancy outcome.Maternal anemia effects during pregnancy on male and female fetuses: are there any differences?Melanocytic skin lesions and pregnancy: digital dermoscopy analysis.Neonatal morbidity after cesarean section before labor at 34(+0) to 38(+6) weeks: a cohort study.Transvaginal ultrasonography in women receiving emergency contraception.Low estrogen oral contraceptives and the hypothalamo-pituitary axis.Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata.Histologic chorioamnionitis: different histologic features at different gestational ages.Weight gain regardless of pre-pregnancy BMI and influence of fetal gender in response to labor induction in postdate pregnancy.Serum activin A and inhibin A. New clinical markers for hydatidiform mole.Histologic chorioamnionitis at term: implications for the progress of labor and neonatal wellbeing.Endometrial expression and secretion of activin A, but not follistatin, increase in the secretory phase of the menstrual cycle.A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis.Fetal neural tube defects: maternal serum and amniotic fluid activin A levels.Virtual fetal touch through a haptic interface decreases maternal anxiety and salivary cortisol.Thickness of fetal membranes: a possible ultrasound marker for preterm delivery.Umbilical cord serum activin A levels are increased in pre-eclampsia with impaired blood flow in the uteroplacental and fetal circulation.The increase of blood flow in the fetal middle cerebral artery correlates with the onset of labor at term.Carbetocin versus oxytocin after caesarean section: similar efficacy but reduced pain perception in women with high risk of postpartum haemorrhage.Fetal gender effects on induction of labor in postdate pregnancies.Ultrasound estimated fetal weight slightly below the median is associated with increased risk of spontaneous preterm birth.Low-molecular-weight heparin improves the performance of uterine artery Doppler velocimetry to predict preeclampsia and small-for-gestational age infant in women with gestational hypertension.Induction of labour: clinical predictive factors for success and failure.Fetal middle cerebral artery Doppler in late-term pregnancy: a predicting factor for failed induction of labor.Placental and maternal serum activin A in spontaneous and induced labor in late-term pregnancy.Expression, localization and control of activin A release from human umbilical vein endothelial cells.
P50
Q28297913-174EE505-A8FA-48A1-9FA1-13D1199E8C4CQ31132787-BFBF0DBA-F253-4A41-B526-4974CECAB50CQ33193323-F8460E48-2F2F-4A28-905A-B199F5DD6E21Q34176878-EE380A3E-A665-431F-A762-F673A8BBB8ECQ34617098-5D43B4C8-6E9C-4ECF-9B67-847A3F899BF8Q35532882-A59E18AA-365B-45DE-838A-DD28A5192FA6Q35903325-65658A38-61C9-4240-B0FD-BA4A8284EBF8Q36861771-DA71D229-F1A3-4148-831C-24C7B3731FA5Q37986113-6455F1E9-EA7F-4883-B0B2-E3130355FC7BQ37991002-88ED6490-DC0B-4FE9-8E83-8168D7C8E511Q38089568-B7F68EA3-6B2A-44C0-8E8D-22C11B53D182Q38828327-347BD8C8-E96D-4EEB-9A1B-2CAC2466B398Q38937593-37C9B197-4C2B-4B58-8174-F70EA7037C88Q39127649-2242FFF4-C555-46A4-A781-8ED54110E95CQ39305827-01716778-85EF-4CEA-BDA2-C425B998CDEAQ39465251-5F8264D3-020D-4680-ADF9-0FC6CBB89718Q39790661-A09F773A-76AE-41F2-A5C7-C31A71CDE11CQ40875543-F7ED23CF-CCCC-498D-A4D0-5D4D11BE4C03Q42035966-AC723015-DAAA-4B4E-B0CB-8C5E46B4318EQ42470525-17F29A96-7317-43EB-81B9-424C23F51AF0Q43538175-A21C7E3E-F90A-4470-8A36-373C9EBD698DQ44012700-5221D70B-999A-4226-AF87-2B71F5EA6B91Q44020313-A9A90A2A-894D-4A65-9732-D97F78AEA8BFQ44098551-D8AD5267-1E1A-4432-8A02-DD66F6107264Q44293858-DDBAC7C5-A793-4486-821E-72AC1EB7672FQ44448650-95B97CBF-DE31-4627-8328-EFFE9F8A5521Q44966195-FE08DC68-82CF-4C67-92D7-95A487D60146Q45011030-EE6EDFCA-E202-4E14-927C-0D3B1DA1F789Q45209697-40A2FA1C-74F6-4468-BD82-DBE869800CB9Q46176509-B2724170-B4C1-45CB-8547-B2456290C7CBQ46624186-E09443F6-2D8E-40F2-BA04-75EDED3F77EAQ46684133-5B45020A-246A-49C8-B894-C1BAD166A596Q46762739-6A1670EE-1217-4C5C-9F55-BF28B8B4B46EQ46852138-E1249398-194F-458D-B126-1B64AEC95A1DQ47314968-80C8E403-65E9-4CE0-9AEF-B1273FAA3F3FQ47322048-A4621C16-2133-402E-B156-C8654570A30BQ47744045-DED0B269-4FEB-497F-897D-498223D12710Q50431745-18A9C6AB-F2A4-452E-9EE0-E9EFF46AB96DQ50435036-3B50CDBF-031B-4FAC-B9E6-5151E302BD57Q50564156-B2A77BA5-C62A-4D8A-8C3E-B006FAA4ECE0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Filiberto M Severi
@ast
Filiberto M Severi
@en
Filiberto M Severi
@es
Filiberto M Severi
@nl
type
label
Filiberto M Severi
@ast
Filiberto M Severi
@en
Filiberto M Severi
@es
Filiberto M Severi
@nl
prefLabel
Filiberto M Severi
@ast
Filiberto M Severi
@en
Filiberto M Severi
@es
Filiberto M Severi
@nl
P106
P1153
7006407557
P31
P496
0000-0002-0892-4561